Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Pickart, L., et al
Anyone monitoring for retatrutide-related hair loss should understand that this typically relates to rapid weight loss rather than direct drug toxicity, and it generally resolves as weight stabilizes
While available studies are promising, more research is needed to confirm the efficacy in skin Might help reduce hyperpigmentation in skin and help neutralize free radicals Can be drying and contribute to skin irritation
Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
